Beximco gets sub-licence to produce Pfizer's Covid drug
Beximco Pharma has got a sub-licence from the United Nations-backed Medicines Patent Pool to produce a generic version of Paxlovid, Pfizer's oral treatment for Covid. Beximco will manufacture this drug– a combination of nirmatrelvir and ritonavir– in Bangladesh following succe...